Outcomes of High-risk Non-muscle Invasive Bladder Cancer Treated With Blue Light Resection

NCT06525571 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

200

Enrollment

OTHER

Sponsor class

Conditions

Bladder Cancer

Interventions

DRUG: Cysview
DEVICE: Karl Storz D-Light C Photodynamic Diagnostic (PDD) system

Sponsor

Johns Hopkins University

Collaborators

[object Object]